Company: SVREW
Filing Date: 2025-07-08
Form Type: 424B3
Source: 0001213900-25-062089
Chunk: 2

Company: SaverOne 2014 Ltd.
Filing Date: 2025-07-08
Form: 424B3
Chunk 2
---
 this prospectus all outstanding amounts under the Promissory Notes have been paid in full.

Yorkville is not required
to subscribe for or acquire any ADSs under the SEPA if those ADSs, when aggregated with all other ADSs or Ordinary Shares acquired by
Yorkville under the SEPA, would result in Yorkville beneficially owning more than 9.99% of the outstanding ADSs or Ordinary Shares.

We are not selling any of
our securities under this prospectus, and we will not receive any of the proceeds from the sale of our securities by Yorkville. We will
bear all costs, expenses and fees in connection with the registration of the ADSs under this prospectus. Yorkville will bear all commissions
and discounts, if any, attributable to sales of the securities registered herein. See “Plan of Distribution.”

See the section titled “The
Yorkville Transaction” for a description of the transaction contemplated by the SEPA and “Selling Shareholder” for additional
information regarding Yorkville.

As of the date of this Prospectus,
we received approximately $10.53 million in aggregate proceeds pursuant to Advances under the SEPA. The amount that we may receive under
the SEPA in the future is difficult to estimate depends on a number of factors, including the frequency and prices at which we issue ADSs
to Yorkville, market conditions and the trading price of our Ordinary Shares, our ability to meet the conditions set forth in the SEPA,
and determinations by us as to the appropriate sources of funding for our company and our operations.

Yorkville is an “underwriter”
within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”),
and any profits on the sales of shares of our ADSs by Yorkville and any discounts, commissions, or concessions received by Yorkville are
deemed to be underwriting discounts and commissions under the Securities Act.

Our Ordinary Shares are listed
on the Tel Aviv Stock Exchange Ltd., or the TASE, under the symbol “SVRE.” The last reported sale price of our ordinary shares
on the TASE on June 30, 2025, was NIS 0.01 or $0.003 per share (based on the exchange rate reported by the Bank of Israel on that date,
which was NIS 3.372 = $1.00).

Our ADSs are listed on the
Nasdaq Capital Market, or Nasdaq, under